Treatment modalities include liver transplantation for transthyretin-related (ATTR) amyloidosis, elimination of inflammation in amyloid A (AA) amyloidosis and intensive chemotherapy in ...

Almost four years after it was approved in Europe to treat the incurable rare disease systemic amyloid light-chain (AL) amyloidosis, Johnson & Johnson’s Darzalex has been given the go-ahead for ...

There are three major subtypes of amyloidosis: primary amyloidosis, secondary amyloidosis, and hereditary amyloidosis (Khan & Falk, 2001; Nakata & Shimamoto, 2003; Smith, 2003). Primary ...

Early clinical diagnosis of an under-recognized form of amyloidosis that causes rapidly progressing polyneuropathy is crucial to improving patient outcomes. Worldwide, the most common mutation ...

The most common nonfamilial forms of amyloidosis that involve the kidney are the AL (amyloid light chain) and AA (serum amyloid A) types. These two forms require different treatment strategies ...